| Literature DB >> 33333447 |
Marie R Southerland1, Michael A DeBord1, Nicholas A Johnson2, Steven R Crabtree1, Nicolas E Alexander1, Michael L Stromyer1, Patrick O Wagers1, Matthew J Panzner1, Chrys Wesdemiotis1, Leah P Shriver1, Claire A Tessier1, Wiley J Youngs3.
Abstract
A series of novel bis-imidazolium salts was synthesized, characterized, and evaluated in vitro against a panel of non-small cell lung cancer (NSCLC) cells. Two imidazolium cores were connected with alkyl chains of varying lengths to develop a structure activity relationship (SAR). Increasing the length of the connecting alkyl chain was shown to correlate to an increase in the anti-proliferative activity. The National Cancer Institute's NCI-60 human tumor cell line screen confirmed this trend. The compound containing a decyl linker chain, 10, was chosen for further in vivo toxicity studies with C578BL/6 mice. The compound was well tolerated by the mice and all of the animals survived and gained weight over the course of the study.Entities:
Keywords: Bis-imidazolium salt; Imidazolium salt; In vivo toxicity; Non-small cell lung cancer; SAR
Mesh:
Substances:
Year: 2020 PMID: 33333447 PMCID: PMC7903221 DOI: 10.1016/j.bmc.2020.115893
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641